Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
about
Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantationAutoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for preventionPneumocystis Pneumonia in Human Immunodeficiency Virus-infected Adults and Adolescents: Current Concepts and Future DirectionsGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveGreat efficacy of sulfachloropyrazine-sodium against acute murine toxoplasmosisEarly impact and performance characteristics of an established anal dysplasia screening program: program evaluation considerationsTreatment of cryptococcosis in the setting of HIV coinfection.Medical management of human immunodeficiency virus infection.Women's rights and women's health during HIV/AIDS epidemics: the experience of women in sub-Saharan Africa.CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection - a retrospective autopsy based study.A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adultsAntibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline.Poppers: epidemiology and clinical management of inhaled nitrite abuse.Risk of healthcare associated infections in HIV positive patients.When to start antiretroviral therapy in resource-limited settings.Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site StudyVaccines for invasive fungal infectionsMolecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients.Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy.Parasitic central nervous system infections in immunocompromised hostsManagement of Pneumocystis pneumonia in patients with inflammatory disorders.Correlations among measures of quality in HIV care in the United States: cross sectional studyPotential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trialCancer prevention in HIV-infected populations.Audit of pneumocystis pneumonia in patients seen by the Christchurch Hospital rheumatology service over a 5-year period.Immunohaematological reference values in human immunodeficiency virus-negative adolescent and adults in rural northern Tanzania.Management strategies for pulmonary sarcoidosis.Low CD4+ T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana.Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease.Pneumocystis jirovecii pneumonia in kidney transplantation.Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors.CMV retinopathy in the antiretroviral therapy era: prevention, diagnosis, and management.Utilization of a basic care and prevention package by HIV-infected persons in Uganda.Pneumocystis pneumonia complicating immunosuppressive therapy in Crohns disease: A preventable problem?Pneumocystis pneumonia during Postoperative Adjuvant Chemotherapy for Breast Cancer.Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.Cerebral Mycobacterium avium abscesses: Late immune reconstitution syndrome in an HIV-1-infected patient receiving highly active antiretroviral therapy.Relationship Between Pneumocystis carinii Burden and the Degree of Host Immunosuppression in an Airborne Transmission Experimental Model.Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination.
P2860
Q24652970-0BAB4B0D-BB02-4163-964D-CA7B4FA99F49Q24791788-0C6835DB-65E8-4F40-96DA-9FE07CDB5D68Q26795592-47B9AF31-CE20-487A-960B-47256AB3140FQ28388806-3F5086E8-3658-4E57-9027-DB9CCAA27EDDQ28396159-FAADC42C-88A4-49E1-86FE-B682EC51B041Q28757222-4E13D5EE-CCD0-4F1F-A16E-99D50C39492AQ30366117-C07D70ED-9ED6-489F-8B8D-7E22F923B869Q30371489-E3334718-8820-4FB3-8794-68842F5F41F5Q30378638-13E56438-662E-4233-B3CA-A0ED95302BC7Q33305154-236BC18A-FAC7-4970-848A-E160D9FB0C4EQ33864631-311B9E7D-EFE4-4BA7-A931-EB6AC0BD8875Q34133346-0C6BFDEB-B5C6-45AF-AD08-947FB950C37FQ34292063-BDAF89B6-AE54-48A4-A268-420D550BA109Q34626712-6BBFCDAD-678C-4DA7-923E-AAA562D015F1Q34974260-B6CD26D6-89E9-4297-8E34-F5261793603AQ35046966-59FCD925-7E56-4B1B-9B96-E9B98C714F3CQ35161720-5D8C8570-447F-4ABB-ABF0-5B3D8200CA87Q35880726-2FCE1BD5-9B5F-4207-BF14-39ECBB48C7EAQ35920640-F0B3C649-F37C-4716-80AE-34B3C74BD50FQ36014872-010A2BD6-FACC-4C7E-B82E-57BD62900F30Q36095864-38077D47-1DE7-45D7-8ACC-EBBD04311EC4Q36162376-ECD17CB5-9E4E-4466-9CD0-5D58513374B2Q36168942-DEE183A8-C532-4EA2-956E-12290E94F81BQ36627942-81E11B8E-98CA-4258-A20F-35EFCD3D741CQ36680086-EEF659C1-320B-40EC-8F89-8D921FA3C015Q36828260-5BCF5993-1E1D-4528-9E91-569426C54ABEQ37072828-23B1CB47-E292-4A04-95DA-0286B89A76F7Q37298242-3E116EB4-3A82-4BF7-8D20-167CC610CCBEQ37495258-73217263-F649-4BDF-BA64-073BB685E150Q37579958-449C9B42-60E3-41FD-AA6E-FFD3B94D0214Q37957313-62A9107D-6CD7-43C9-8C5B-26C173775D91Q37987077-C1A8BD1F-ED4D-4930-8D36-E2E2AD754295Q38017949-EEE0ACAE-9D92-41B9-BCF0-EB895AA580A1Q38877456-279C0F39-E7E5-442C-AF91-528D133A4541Q40080089-584785F1-9996-4AA2-8230-89F4231C7597Q40244622-32F87AA6-2971-45EC-83AC-0A9B233B526FQ40669533-1E3E4463-875A-4775-926E-0155850BA37AQ40670627-7C69B703-A6C5-4849-9CFB-7E8B6356D9FFQ40934244-E7141FB5-A337-485D-BB82-EFCC726BD84CQ40992209-9266CE53-9546-4C04-92EB-B615FEE3935F
P2860
Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Guidelines for preventing oppo ...... s Diseases Society of America.
@en
type
label
Guidelines for preventing oppo ...... s Diseases Society of America.
@en
prefLabel
Guidelines for preventing oppo ...... s Diseases Society of America.
@en
P2093
P1476
Guidelines for preventing oppo ...... s Diseases Society of America.
@en
P2093
Henry Masur
Jonathan E Kaplan
King K Holmes
U.S. Public Health Service
P304
P356
10.7326/0003-4819-137-5_PART_2-200209031-00002
P407
P433
P577
2002-09-01T00:00:00Z